Biotech Computer Healthcare Hong Kong Medicine Pacific Pharmaceutical private equity Robotics Singapore
Investors are increasingly turning their attention to cutting-edge healthcare technologies such as brain-computer interfaces and surgical robotics in Asia, driven by the region’s booming biotechnology sector. William Chow, deputy group CEO of Raffles Family Office based in Hong Kong and Singapore, emphasized the growing demand for advanced surgery and medicine in the aging Asian population. The surge in healthcare deal activity is evidenced by the doubling of healthcare private equity funds involved in Asia-Pacific deals, reaching 129 in the first half of the year, up from 66 a year earlier according to Bain & Company data. Despite a global decline…
News Timeline:
Track the development of this news story across the Internet.